Z-1792-2023 Class I Ongoing

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-1792-2023 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on May 10, 2023 and is designated Class I. Reason for recall: There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy… The recall status is ongoing. Affected quantity: 12 units.

Recall details

Product Type
Devices
Report Date
Jun 28, 2023
Initiation Date
May 10, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12 units

Product description

ICD-VR VISIA AF XT OUS DF4, Model Number DDVAB2D4; Implantable Cardioverter Defibrillators

Reason for recall

There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

Distribution pattern

US Nationwide - Worldwide Distribution

Code information

GTIN 00643169720763, Lot Serial Numbers: BWT600023S, BWT600013S, BWT600014S, BWT600025S, BWT600029S, BWT600030S, BWT600032S, BWT600033S, BWT600034S, BWT600024S,; GTIN 00763000052706, Lot Serial Numbers: BWT600040S, BWT600038S

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1792-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1792-2023. Report a data issue: hello@regdatalab.com.